U.S. Markets open in 58 mins

[$$] Drug Tests in South Korea

While you watch the Pyeongchang Winter Olympics, you may want to check out some other national champions who’ve been catching big air in South Korea–namely, the shares of the Korean biotech firms Celltrion and Samsung Biologics. Both firms are the biotech industry equivalent of a generic drug maker, brewing “biosimilar” versions of off-patent products like the arthritis treatment Remicade from Johnson & Johnson (JNJ) or the cancer drug Herceptin from Roche Holding (ROG.Switzerland). Since their 2005 debut on Korea’s tech-oriented Kosdaq exchange, Celltrion shares (068270.KQ) have risen 50-fold in a Bitcoin-like mania that made Celltrion the most actively traded stock in Asia last year.